MENU
NVO
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Novo-Nordisk A/S (NVO) Ownership - Who owns Novo-Nordisk A/S?
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
299.85B
P/E Ratio
18.63
Total Cash
41.55B
Projected Growth
1.31
Total Debt
118.72B
Revenue
303.14B
Risk (Beta)
0.67
Dividend Yield
0.02
Total Cash/Share
9.35
Total Debt/Equity
2.39
Revenue/Share
10.65 USD as % of share price
Fundamentals
NVO
Capitalization
300B
P/E Ratio
18.63
Risk (Beta)
0.67
Dividend Yield
0.02
Total Cash
41.6B
Total Cash/Share
9.35
Total Debt
119B
Total Debt/Equity
2.39
Projected Growth (PEG Ratio)
1.31
Revenue/Share (as % of the share price)
10.65%
Revenue
303B
ROE
N/A
Book Value
139B
P/B Ratio
14.03
Cash Flow
N/A
Earnings
23.51
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
446M
Current Ratio
0.74
Current Revenue Per Employee
1008797.75
Dividends Per Share - Security
7.58
EBITDA
147B
Float
N/A
Float - Current
N/A
Gross Income Margin
83.49
Revenue To Assets
26.55
Shares Held By Institutions
79.6B
Shares Outstanding - Current
4.44B
Total Liabilities
351B
Total Volume MTD
N/A
Value
1
Gain YTD
-19.072
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com